Navigation Links
Oncology Global Strategic Marketing Study Offers Chance for Resource Benchmarks

CHAPEL HILL, N.C., April 19, 2011 /PRNewswire/ -- The oncology market continues to be a rapid growth area for the biopharmaceutical industry, but managing all the aspects of successfully launching a new oncology product is challenging. In particular, global strategic marketing functions supporting the oncology therapeutic area are constantly assessing the appropriate budgets and resources needed to run a high-performing group.

Best Practices, LLC, a leader in biopharmaceutical benchmark and best practice research, has launched a comprehensive study to answer questions such as:

  • Annual cost for Oncology Global Strategic Marketing operations
  • Total number of FTEs
  • Percentage of FTEs and budget allocated to six key activities
  • Current investment level trends
  • Key activities at each stage of product development

Pharma Leaders who oversee or work in Global Strategic Marketing for Oncology are invited to participate in the online survey and receive the full results at no cost. The study looks at Oncology Global Strategic Marketing activities in the United States, Europe, Asia or other headquarters locations and major markets.

This study will generate comparative metrics and executive insights that participants can use to evaluate and improve the effectiveness of their individual programs. All responses are blinded and aggregated to protect confidentiality. To participate, follow this link to the study:

For assistance or questions related to this study, contact research team leader Martha Haswell at or (919) 767-9249. Responses are requested by April 25, 2011.


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for 17 years; our clients include 48 out of the top 50 pharmaceutical companies. For more information visit:

SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
(Date:11/24/2015)... CHICAGO , November 24, 2015 st ... North America (RSNA) taking place in ... in Booth 1122, Hall A. --> st  Scientific Assembly ... America (RSNA) taking place in Chicago ... 1122, Hall A. --> Molecular Dynamics will present its ...
(Date:11/24/2015)... The uptake of recently approved and pipeline premium products for Type ... to 2021, says GBI Research . --> ... 1 Diabetes Mellitus (T1DM), will be a key driver of market growth ... The uptake of recently approved and pipeline premium products for ... growth to 2021, says GBI Research . ...
(Date:11/24/2015)... (NASDAQ: IMMY ) is a national leader ... compounded pharmaceuticals.  The company,s business primarily consists of ... integrative medicine.  Imprimis dispenses compounded pharmaceuticals in all ... California , Texas ... Pennsylvania.  For more information about Imprimis, please visit ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Charitable giving is at its peak during the holidays. In fact, ... the year totalling over $358 billion in 2014. With more than 1.5 million ... individuals who want to “give back” during the holidays. , “With so many charities ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... are national leaders when it comes to several aspects of orthopedic care. They ... joint replacements, orthopedic surgeries and general orthopedic care. , Becker's Hospital Review ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... In response ... growing epidemic as deaths from prescription opioids in the United States grew 400 percent ... In 2013 alone, opioids were involved in 37 percent of all fatal drug overdoses. ...
(Date:11/24/2015)... , ... November 24, 2015 , ... Serenity Point Rehabilitation, ... series of recent video interviews with some of the staff members at their recovery ... residential treatment facility, as well as some of the things that make their recovery ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic ... University-Kansas City (CU-KC), in Overland Park, Kansas. Benson, a fifth-trimester student in ... Carl S. Cleveland III on October 16. , “Katie is very excited and ...
Breaking Medicine News(10 mins):